Menu
Home
About Us
About 340B Report
Who We Are
Testimonials
Sample Issue
Subscribe
Contact
Subscriber FAQ
Sponsor/Advertise
Why Sponsor?
340B Report Sponsors
Resource Center
Document Center
Special Reports
Webinars
Article Archives
340B Leaders
Industry Insights
Spotlights
340B Industry Leaders
340B Provider Leaders
Our Sponsors
Expert Directory
Expert Tips
Events Calendar
340B Trackers
Congressional 340B Bill Tracker
State Contract Pharmacy Bills & Laws
State Provider Reporting Bills & Laws
State PBM Reimbursement Laws
Drugmaker State Exemptions Tracker
Subscribe
Sign in
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
340B Report
Drugmaker Novartis filed suit to block Maryland's recently signed 340B contract pharmacy statute.
Novartis to Refund Covered Entities After Adjusting 340B Ceiling Prices for 100-Plus Products
April 23, 2024
Shannon Young, Associate Editor/Senior Writer
Views
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
Please be sure you’ve completed your
one-minute subscription completion form
.
I have read and accepted the
terms of use
and
privacy policy
.
Log In!
If you are not yet a paid subscriber, please
Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
reshma.eggleston@340breport.com
.
Shannon Young